• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PDSB

PDSB

PDS Biotechnology Corporation

NASDAQHealthcareBiotechnologyUS

USD1.08

-0.08 (-6.90%)

Rating:C-

Company Profile

CEO

Frank K. Bedu-Addo

IPO Date

2015-09-30

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.17

Prev. Close

$1.16

Day Low

$1.08

Day High

$1.17

52W Low

$0.51

52W High

$1.92

Market Cap

$0.06B

Volume

0.73M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.4%

Avg Negative

6.8%

Avg Neutral

56.7%

News Feed

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of PDS Biotechnology Corporation - PDSB

Newsfile Corp·7/12/2021·↓ negative

PDS Biotechnology Joins Russell Microcap® Index

GlobeNewsWire·7/1/2021·↑ positive

NetScientific gives further backing to PDS Biotechnology

Proactive Investors·6/22/2021·↓ negative

PDSB Stock Price Increases Over 15%: Why It Happened

Pulse2·6/18/2021·↑ positive

PDS Biotechnology Corporation Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

GlobeNewsWire·6/17/2021·↑ positive

NetScientific: City broker provides thumbs up following PDS funding round

Proactive Investors·6/16/2021·↑ positive

NetScientific follows its money as investee company announces plans to raise US$45mln

Proactive Investors·6/16/2021·↑ positive

PDS Biotech Announces Proposed Offering of Common Stock

GlobeNewsWire·6/14/2021·↑ positive

Why PDSB Shares Are Trading Higher Today

Benzinga·6/8/2021·↑ positive

NetScientific on the rise again after PDS cancer trial

Proactive Investors·6/8/2021·↑ positive